NCT06994832

Brief Summary

The goal of this study is to understand how people understand risk from genetic testing. The investigators want to understand what visual aid best helps people accurately assess risk. The investigators also want to understand how people relate risk to their health. The main questions the study aims to answer are:

  1. 1.Which visual aid most accurately show genetic risk?
  2. 2.How do people perceive risk related to genetic test results?
  3. 3.What factors are associated with people discussing their results with family?
  4. 4.receive of of two visual aids showing risk
  5. 5.state their estimation of risk
  6. 6.answer questions about how they feel about risk and sharing information with family

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,045

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 29, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

July 28, 2025

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 18, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 18, 2025

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

September 24, 2026

Completed
Last Updated

September 24, 2026

Status Verified

September 1, 2025

Enrollment Period

21 days

First QC Date

April 22, 2025

Results QC Date

July 10, 2026

Last Update Submit

August 30, 2026

Conditions

Keywords

Lynch syndromecolorectal cancercolon cancergenetic testing

Outcome Measures

Primary Outcomes (1)

  • Perceived Overall Accuracy of General Population Risk for Colorectal Cancer Prior to Seeing Array

    Differences between closest approximation to risk percentage depicted in the visual array that depicted risk with Lynch Syndrome (LS) minus risk without LS

    immediately after the intervention

Secondary Outcomes (5)

  • Accuracy of Risk for Colorectal Cancer for Someone Without Lynch Syndrome (Without Gene Mutation) From the Array

    immediately after the intervention

  • Accuracy of Risk for Colorectal Cancer for Someone With Lynch Syndrome From the Array

    immediately after the intervention

  • Risk Perceptions - Percent

    baseline

  • Risk Perceptions - 7-point Likert-type Scale

    baseline

  • Communication Intent

    immediately after the intervention

Study Arms (4)

Visual Array & Choice

EXPERIMENTAL

Single, side-by-side visual array and non-directive decision frame

Behavioral: Visual ArrayBehavioral: Choice

Visual Array and Enhanced Choice

EXPERIMENTAL

Single, side-by-side visual array and decision frame with subjective norms nudge

Behavioral: Visual ArrayBehavioral: Enhanced Choice

Narrative Visual Array and Choice

EXPERIMENTAL

Evolving narrative showing sequential visual arrays and non-directive decision frame

Behavioral: Narrative Visual ArrayBehavioral: Choice

Narrative Visual Array and Enhanced Choice

EXPERIMENTAL

Evolving narrative showing sequential visual arrays and decision frame with subjective norms nudge

Behavioral: Narrative Visual ArrayBehavioral: Enhanced Choice

Interventions

Visual ArrayBEHAVIORAL

Single side-by-side visual array

Visual Array & ChoiceVisual Array and Enhanced Choice

Evolving narrative with sequential visual arrays

Narrative Visual Array and ChoiceNarrative Visual Array and Enhanced Choice
ChoiceBEHAVIORAL

Non-directive decision frame

Narrative Visual Array and ChoiceVisual Array & Choice
Enhanced ChoiceBEHAVIORAL

Decision frame with subjective norms nudge

Narrative Visual Array and Enhanced ChoiceVisual Array and Enhanced Choice

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ability to read and understand English
  • opt-in consent

You may not qualify if:

  • incorrect responses to validation questions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston College

Boston, Massachusetts, 02467, United States

Location

Related Publications (1)

  • Keels JN, Babicheva V, McDonald IR, Witt JK, Dwyer AA. Optimizing Risk Communication for Lynch Syndrome: Results of a Randomized Controlled Trial of Visual Arrays for Genetic Testing. Cancers (Basel). 2026 Apr 25;18(9):1369. doi: 10.3390/cancers18091369.

MeSH Terms

Conditions

Colorectal Neoplasms, Hereditary NonpolyposisColorectal NeoplasmsColonic Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsNeoplastic Syndromes, HereditaryDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDNA Repair-Deficiency DisordersMetabolic DiseasesNutritional and Metabolic DiseasesRectal Diseases

Results Point of Contact

Title
Stephanie Seminara
Organization
Massachusetts General Hospital

Study Officials

  • Andrew A Dwyer, PhD

    Boston College

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: One-to-one randomization into two parallel groups (Array Period); One-to-one randomization into two additional parallel groups (Family Communication Period)
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chief, Reproductive Endocrine Unit; Professor of Medicine, Harvard Medical School; Director, MGH Harvard Center for Reproductive Medicine

Study Record Dates

First Submitted

April 22, 2025

First Posted

May 29, 2025

Study Start

July 28, 2025

Primary Completion

August 18, 2025

Study Completion

August 18, 2025

Last Updated

September 24, 2026

Results First Posted

September 24, 2026

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

Anonymized data will be shared via the HarvardDataverse platform.

Time Frame
Start date: within one month of the publication of study results. End date: one year after posting.
Access Criteria
HarvardDataverse platform
More information

Locations